{
"PCVX": "Vaxcyte stock sinks despite Phase II IPD vaccine trial success ",
"RIOT": "Riot Platforms (NasdaqCM:RIOT) Sees 18% Drop In Last Week Despite Increased Bitcoin Production",
"LEVI": "Levi Strauss expands direct-to-consumer strategy in Europe",
"PFE": "Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?Is Pfizer Inc. (PFE) the Most Undervalued Healthcare Stock to Buy According to Analysts?Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK3 Ultra-High-Yield Dividend Stocks to Buy in AprilFormer Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the ‘big questions’",
"PRGS": "Progress Software First Quarter 2025 Earnings: Beats ExpectationsThese Stocks Moved the Most Today: Tesla, Johnson & Johnson, Southwest, Delta, MicroStrategy, PVH, Newsmax, and MoreProgress Software 'Solid' Demand, Lower Churn, M&A Strategy Drive Optimistic Outlook, Wedbush SaysProgress Software's M&A Strategy Likely to Benefit From Tough Macro Environment, Oppenheimer SaysProgress Software Stock Jumps on AI Firm's Better-Than-Expected Results, OutlookQ1 2025 Progress Software Corp Earnings CallProgress Software Corp (PRGS) Q1 2025 Earnings Call Highlights: Strong Financial Performance ..."
}